Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in children
- PMID: 18806661
- DOI: 10.1097/IOP.0b013e3181831f56
Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in children
Abstract
Purpose: To determine the outcome and safety of pediatric endonasal dacryocystorhinostomy with the use of adjunctive mitomycin C.
Methods: A prospective, nonrandomized and noncomparative interventional case series study was performed in 71 consecutive procedures. Sixty patients 16 years of age and younger underwent nonlaser endonasal dacryocystorhinostomy with the use of adjunctive mitomycin C. Eleven patients had a simultaneous bilateral procedure performed. All patients underwent a standardized procedure, with an endonasal approach to the lacrimal sac and surgical removal of nasal mucosa, lacrimal bone, and a fragment of the frontal process of the maxilla. The medial wall of the lacrimal sac was completely removed and a neurosurgical cottonoid soaked in mitomycin C at 0.5 mg/ml placed at the osteotomy site for 5 minutes. All patients underwent bicanalicular or monocanalicular silicone intubation.
Results: The main outcome measures were the resolution of epiphora, lacrimal discharge, and patency of the ostium confirmed either by endoscopic visualization and/or irrigation at 6 months or a normal dye disappearance test. Thirteen patients' (18%) final evaluation was via telephone survey. The mean follow-up was 12.3 months. Nonlaser endonasal dacryocystorhinostomy with adjunctive mitomycin C was successful in 67 cases (94.4%). African descent was strongly associated with a higher rate of obstruction (p < 0.001). Infection at the time of surgery (p = 0.051) and less than 3 months intubation (p = 0.059) were also borderline significant. Previous trauma, gender, age, and side operated had no influence on the final outcome. No significant complications were encountered.
Conclusions: Nonlaser endonasal dacryocystorhinostomy with mitomycin C is a safe and successful procedure for the treatment of congenital nasolacrimal duct obstruction in children. It has the advantage of leaving no scar and of preserving the medial canthal structures. It can be successfully performed as a simultaneous bilateral procedure.
Similar articles
-
Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults.Ophthalmology. 2010 May;117(5):1037-40. doi: 10.1016/j.ophtha.2009.09.028. Epub 2010 Jan 15. Ophthalmology. 2010. PMID: 20079535
-
Endoscopic dacryocystorhinostomy not using canalicular silicone intubation tube with and without mitomycin C: a comparative study.Eur J Ophthalmol. 2012 May-Jun;22(3):320-5. doi: 10.5301/ejo.5000048. Eur J Ophthalmol. 2012. PMID: 21948027
-
Circumostial injection of mitomycin C (COS-MMC) in external and endoscopic dacryocystorhinostomy: efficacy, safety profile, and outcomes.Ophthalmic Plast Reconstr Surg. 2014 Mar-Apr;30(2):187-90. doi: 10.1097/IOP.0000000000000102. Ophthalmic Plast Reconstr Surg. 2014. PMID: 24614551
-
Evidence-based review of surgical practices in endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction and other new indications.Curr Opin Ophthalmol. 2014 Sep;25(5):443-8. doi: 10.1097/ICU.0000000000000084. Curr Opin Ophthalmol. 2014. PMID: 24979582 Review.
-
A meta-analysis of primary external dacryocystorhinostomy with and without mitomycin C.Ophthalmic Epidemiol. 2012 Dec;19(6):364-70. doi: 10.3109/09286586.2012.733792. Ophthalmic Epidemiol. 2012. PMID: 23171205 Review.
Cited by
-
Topical mitomycin in endoscopic-assisted probing for the treatment of congenital nasolacrimal duct obstruction in older children.Arq Bras Oftalmol. 2020 Jun;83(3):229-235. doi: 10.5935/0004-2749.20200062. Epub 2020 May 29. Arq Bras Oftalmol. 2020. PMID: 32490970 Free PMC article.
-
Effects of Merogel coverage on wound healing and ostial patency in endonasal endoscopic dacryocystorhinostomy for primary chronic dacryocystitis.Eye (Lond). 2011 Jun;25(6):746-53. doi: 10.1038/eye.2011.44. Epub 2011 Mar 11. Eye (Lond). 2011. PMID: 21394118 Free PMC article. Clinical Trial.
-
Primary nonendoscopic endonasal versus external dacryocystorhinostomy in nasolacrimal duct obstruction in children.Indian J Ophthalmol. 2017 Oct;65(10):1004-1007. doi: 10.4103/ijo.IJO_188_17. Indian J Ophthalmol. 2017. PMID: 29044069 Free PMC article.
-
Application of S-100 absorbable hemostatic patch in endonasal endoscopic dacryocystorhinostomy: A randomized controlled trial.Indian J Ophthalmol. 2025 Feb 1;73(2):199-204. doi: 10.4103/IJO.IJO_1229_24. Epub 2025 Jan 24. Indian J Ophthalmol. 2025. PMID: 39853139 Free PMC article. Clinical Trial.
-
Results of nonendoscopic endonasal dacryocystorhinostomy.Clin Ophthalmol. 2012;6:1297-301. doi: 10.2147/OPTH.S33030. Epub 2012 Aug 13. Clin Ophthalmol. 2012. PMID: 22927743 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical